Malkan, Ü. Y. Et Al. 2015. Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib. ANNALS OF PHARMACOTHERAPY , vol.49, no.6 , 740-742.

Malkan, Ü. Y., GÜNEŞ, G., ETGÜL, S., Aslan, T., Balaban, S., & HAZNEDAROĞLU, İ. C., (2015). Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib. ANNALS OF PHARMACOTHERAPY , vol.49, no.6, 740-742.

Malkan, ÜMİT Et Al. "Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib," ANNALS OF PHARMACOTHERAPY , vol.49, no.6, 740-742, 2015

Malkan, ÜMİT Y. Et Al. "Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib." ANNALS OF PHARMACOTHERAPY , vol.49, no.6, pp.740-742, 2015

Malkan, Ü. Y. Et Al. (2015) . "Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib." ANNALS OF PHARMACOTHERAPY , vol.49, no.6, pp.740-742.

@article{article, author={ÜMİT YAVUZ MALKAN Et Al. }, title={Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib}, journal={ANNALS OF PHARMACOTHERAPY}, year=2015, pages={740-742} }